420 results on '"Schwartz JS"'
Search Results
2. CHANGING INDICATIONS FOR LAPAROSCOPIC CHOLECYSTECTOMY
- Author
-
Shea, JA, Bachwich, DR, Escarce, JJ, Staroscik, RN, Malet, PF, and Schwartz, JS
- Published
- 1996
3. The Unmet Need for Postacute Rehabilitation Among Medicare Observation Patients: A Single-Center Study
- Author
-
Banks Tl, Schwartz Js, Patricia McGraw, Jennifer N. Goldstein, and LeRoi S. Hicks
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Leadership and Management ,medicine.medical_treatment ,Hospitals, Community ,Assessment and Diagnosis ,Single Center ,Medicare ,Unmet needs ,Tertiary Care Centers ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Medicine ,Electronic Health Records ,Humans ,Care Planning ,Aged ,Health Services Needs and Demand ,Rehabilitation ,business.industry ,Health Policy ,Medical record ,Electronic medical record ,030208 emergency & critical care medicine ,General Medicine ,Length of Stay ,Middle Aged ,Case management ,medicine.disease ,Patient Discharge ,United States ,Hospital medicine ,Emergency medicine ,Acute Disease ,Fundamentals and skills ,Observational study ,Female ,Medical emergency ,business - Abstract
BACKGROUND Medicare beneficiaries admitted under observation status must pay for postacute inpatient rehabilitation (PAIR) services, out of pocket, at potentially prohibitive costs. OBJECTIVE To determine if there is an unmet need for PAIR among Medicare observation patients and if this care is associated with longer hospital stay and increased rehospitalization. DESIGN/SETTING Observational study using electronic medical record and administrative data from a regional health system. PATIENTS 1323 community-dwelling Medicare patients admitted under observation status. MEASUREMENTS Summary statistics were calculated for demographic and administrative variables. Physical therapy (PT) and case management recommendations for a representative sample of 386 medical records were reviewed regarding need for PAIR services. Linear regression was used to measure the association between PT recommendation and hospital length of stay, adjusting for ICD-9 (International Classification of Diseases, Ninth Revision) diagnosis, age, sex, and provider. Chi-square test was used to determine the association between PT recommendation and 30-day hospital revisit. RESULTS Of the 1323 study patients, 11 (0.83%) were discharged to PAIR facilities. However, 17 (4.4%) of the 386 patients whose charts were reviewed received a recommendation for this care. Adjusted mean hospital stay was longer (P ⟨ 0.001) for patients recommended for rehabilitation (75.9 h) than for patients with no PT needs (46.8 h). In addition, the 30-day hospital revisit rate was higher (P = 0.037) for the patients who had been recommended for rehabilitation (52.9%, 9/17) than for those who had not (25.4%, 30/118). CONCLUSIONS Medicare observation patients' potential need for PAIR services is 5- to 6-fold higher than their use of these services. Observation patients recommended for this care may have worse outcomes. Journal of Hospital Medicine 2017;12:168-172.
- Published
- 2017
4. Value of Organoids from Comparative Epithelia Models
- Author
-
Schwartz, JS, de Jonge, Hugo, Ferrest, JN Jr, and Gastroenterology & Hepatology
- Published
- 2015
5. Predicting Bacteremia in Patients with Sepsis Syndrome
- Author
-
David W. Bates, Johnson Bl, Julie Parsonnet, Patricia L. Hibberd, Kathleen Kahn, Black E, Richard Platt, David R. Snydman, Ashish K. Jha, Schwartz Js, Paul S. Graman, Elizabeth B. Miller, Richard D. Moore, Paul N. Lanken, and Kenneth Sands
- Subjects
medicine.medical_specialty ,business.industry ,Clinical prediction rule ,bacterial infections and mycoses ,medicine.disease ,medicine.disease_cause ,Systemic inflammatory response syndrome ,Infectious Diseases ,Staphylococcus aureus ,Bacteremia ,Internal medicine ,medicine ,Immunology and Allergy ,Risk factor ,Intensive care medicine ,Prospective cohort study ,business ,Mycosis ,Fungemia - Abstract
The goal of this study was to develop and validate clinical prediction rules for bacteremia and subtypes of bacteremia in patients with sepsis syndrome. Thus, a prospective cohort study, including a stratified random sample of 1342 episodes of sepsis syndrome, was done in eight academic tertiary care hospitals. The derivation set included 881 episodes, and the validation set included 461. Main outcome measures were bacteremia caused by any organism, gram-negative rods, gram-positive cocci, and fungal bloodstream infection. The spread in probability between low- and high-risk groups in the derivation sets was from 14.5% to 60.6% for bacteremia of any type, from 9.8% to 32.8% for gram-positive bacteremia, from 5.3% to 41.9% for gram-negative bacteremia, and from 0.6% to 26.1% for fungemia. Because the model for gram-positive bacteremia performed poorly, a model predicting Staphylococcus aureus bacteremia was developed; it performed better, with a low- to high-risk spread of from 2.6% to 21.0%. The prediction models allow stratification of patients according to risk of bloodstream infections; their clinical utility remains to be demonstrated.
- Published
- 1997
- Full Text
- View/download PDF
6. Hospitals' Motivations in Establishing or Closing Geriatric Evaluation Management Units: Diffusion of a New Patient-Care Technology in a Changing Health Care Environment
- Author
-
Lavizzo-Mourey Rj, Alan L. Hillman, Diserens D, and Schwartz Js
- Subjects
Geriatrics ,Motivation ,Aging ,medicine.medical_specialty ,Descriptive statistics ,Physics::Instrumentation and Detectors ,business.industry ,Data Collection ,media_common.quotation_subject ,Specific-information ,Closing (real estate) ,Staffing ,Health Facility Closure ,Test (assessment) ,Nursing ,Health care ,medicine ,Humans ,business ,Geriatric Assessment ,Hospital Units ,Reimbursement ,Aged ,media_common - Abstract
BACKGROUND Although Geriatric Evaluation Management Units (GEMs) are beneficial to patients, they are still new and their adoption by hospitals is unknown. This study describes the adoption of GEMs in a large sample of hospitals, and explores the reasons underlying hospitals' decisions to open (and sometimes close) an inpatient GEM. METHODS A nationwide mail survey was conducted of 3,655 hospitals. The survey asked whether the hospital had an operating GEM, had a GEM that closed, had considered opening a GEM (but had not done so), or had not considered opening a GEM. The survey also requested specific information about operating or closed GEMs. Descriptive statistics, chi-square, t-tests, one-way analysis of variance, and Tukey's standardized range test for multiple comparison of means were used to analyze the responses. RESULTS Among the 1,639 responding hospitals, 159 had established GEMs, 200 were evaluating the possibility of opening a GEM, and 1,263 had neither opened nor considered opening a GEM. Adopters were more likely to be large, urban, teaching hospitals. Evaluators were more optimistic than adopters about GEM's potential to meet financial goals. GEMs that closed tended to be located in hospitals experiencing budget deficits. Among adopters, space and nonphysician staffing were the most critical barriers to establishing a GEM whereas, for evaluators, identifying reimbursement sources and physician staffing were the greatest barriers. VA GEMs are smaller and initiated for different reasons than non-VA hospital GEMs. CONCLUSIONS Despite their demonstrated usefulness, the adoption of GEMs has been limited. The reasons underlying decisions to adopt this new technology or close a GEM are often related to financial, not clinical concerns.
- Published
- 1993
- Full Text
- View/download PDF
7. Myths and realities surrounding health reform
- Author
-
Kevin G. Volpp and Schwartz Js
- Subjects
business.industry ,Health Care Reform ,Medicine ,Health Care Costs ,General Medicine ,Mythology ,Health Expenditures ,Public administration ,business ,United States ,Health reform - Published
- 1994
- Full Text
- View/download PDF
8. PD02-02: A Decision Analysis of Contralateral Prophylactic Mastectomy in Women Undergoing Treatment for Sporadic Unilateral Breast Cancer.
- Author
-
Lester-Coll, NH, primary, Lee, JM, additional, Gogineni, K, additional, Hwang, W-T, additional, Schwartz, JS, additional, and Prosnitz, RG, additional
- Published
- 2011
- Full Text
- View/download PDF
9. The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations
- Author
-
Gray, SW, primary, Hornik, RC, additional, Schwartz, JS, additional, and Armstrong, K, additional
- Published
- 2011
- Full Text
- View/download PDF
10. PHP73 APPLYING KEY PRINCIPLES FOR IMPROVED HEALTH TECHNOLOGY ASSESSMENT: AN ANALYSIS OF 14 HTA ORGANIZATIONS
- Author
-
Neumann, PJ, primary, Drummond, MF, additional, Jönsson, B, additional, Luce, B, additional, Schwartz, JS, additional, Siebert, U, additional, and Sullivan, SD, additional
- Published
- 2009
- Full Text
- View/download PDF
11. CV3 COST-EFFECTIVENESSS OF INTENSIVE STATIN THERAPY COMPARED TO MODERATE STATIN THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: ANALYSIS FROM CANADA, GERMANY AND THE UK
- Author
-
Drummond, MF, primary, Schwartz, JS, additional, Koren, M, additional, Cannon, C, additional, Davie, A, additional, Shui, A, additional, Murphy, S, additional, and Graff, J, additional
- Published
- 2006
- Full Text
- View/download PDF
12. PCV5 PREDICTORS OF ADHERENCE WITH CONCOMITANT ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY
- Author
-
Chapman, RH, primary, Benner, JS, additional, Petrilla, AA, additional, Tierce, JC, additional, Battleman, DS, additional, and Schwartz, JS, additional
- Published
- 2004
- Full Text
- View/download PDF
13. OP0138 Relative gastrointestinal toxicity of cox-2 specific and traditional nsaids in a high-risk population from a health maintenance organisation
- Author
-
Pettitt, D, primary, Goldstein, JL, additional, Singh, G, additional, Schwartz, JS, additional, and Burke, TA, additional
- Published
- 2001
- Full Text
- View/download PDF
14. BT4: COST-EFFECTIVENESS OF HIGH VERSUS LOW DOSE ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEIs) IN THE TREATMENT OF CHRONIC HEART FAILURE (CHF): AN ECONOMIC ANALYSIS OF THE US ASSESSMENT OF TREATMENT WITH LISINOPRIL AND SURVIVAL (ATLAS) TRIAL
- Author
-
Schwartz, JS, primary, Wang, Y, additional, and Cleland, J, additional
- Published
- 2000
- Full Text
- View/download PDF
15. PCDI7: THE EFFECTS OF PAYOR STATUS ON PROCEDURE USE AND OUTCOMES OF PATIENTS WITH CONGESTIVE HEART FAILURE
- Author
-
Kroch, E, primary, Loh, E, additional, Schwartz, JS, additional, Shah, R, additional, and Fisher, D, additional
- Published
- 2000
- Full Text
- View/download PDF
16. Cost Savings in Duodenal Ulcer Therapy Through Helicobacter pylori Eradication Compared With Conventional Therapies<subtitle>Results of a Randomized, Double-blind, Multicenter Trial</subtitle>
- Author
-
Nimish Vakil, Bernard S. Bloom, Cutler Af, Schwartz Js, and Sonnenberg A
- Subjects
medicine.medical_specialty ,Randomization ,Combination therapy ,biology ,business.industry ,Helicobacter pylori ,biology.organism_classification ,Gastroenterology ,Ranitidine ,Clinical trial ,Internal medicine ,Multicenter trial ,Clarithromycin ,Internal Medicine ,medicine ,business ,Omeprazole ,medicine.drug - Abstract
Background We hypothesized that treatment of duodenal ulcer disease with antibiotic therapy directed toward Helicobacter pylori infection is more cost-effective than therapy with antisecretory agents. Methods A randomized, double-blind, multicenter clinical trial of adult patients with active duodenal ulcer and H pylori infection was conducted. Patients were randomized to receive 500 mg of clarithromycin 3 times a day plus 40 mg of omeprazole daily for 14 days followed by 20 mg of omeprazole daily for an additional 14 days (group 1), 20 mg of omeprazole daily for 28 days (group 2), or 150 mg of ranitidine hydrochloride twice a day for 28 days (group 3). The use of ulcer-related health care resources was documented during monthly interviews for 1 year after the initial therapy. Clinical success was evaluated 4 to 6 weeks and 1 year after the end of therapy. Results Of the 819 patients enrolled, 727 completed the study. Group 1 included 243 patients; group 2, 248 patients; and group 3, 236 patients. Patients in group 1 used fewer ulcer-related health care resources during the 1 year after therapy compared with groups 2 and 3 (comparisons are given as group 1 vs group 2 and group 1 vs group 3, respectively): the number of endoscopies performed, 28 vs 76 ( P P P P P =.05) and vs 161 ( P P =.045) and vs 6 ( P =.02); and length of hospital stay, 0 vs 24 days ( P =.04) and vs 37 ( P =.04). When ulcer-related costs were defined as the outcome variable in a multivariate linear regression analysis, therapy was determined to have a significant influence on costs (group 1 vs group 2, P P =.008). Clinical success rates at the end of the study and cure of H pylori infection were significantly greater in group 1 compared with groups 2 and 3 ( P Conclusions Combination therapy with clarithromycin and omeprazole resulted in significantly fewer uses of ulcer-related health care resources than conventional antisecretory therapy during a 1-year follow-up and significant savings in associated costs during the same period. Patients who received clarithromycin plus omeprazole also showed a significantly improved clinical outcome compared with patients who received only omeprazole or ranitidine.
- Published
- 1998
- Full Text
- View/download PDF
17. Prior experiences of racial discrimination and racial differences in health care system distrust.
- Author
-
Armstrong K, Putt M, Halbert CH, Grande D, Schwartz JS, Liao K, Marcus N, Demeter MB, Shea JA, Armstrong, Katrina, Putt, Mary, Halbert, Chanita H, Grande, David, Schwartz, Jerome Sanford, Liao, Kaijun, Marcus, Noora, Demeter, Mirar B, and Shea, Judy A
- Published
- 2013
- Full Text
- View/download PDF
18. Effect of the medicare part d coverage gap on medication use among patients with hypertension and hyperlipidemia.
- Author
-
Li P, McElligott S, Bergquist H, Schwartz JS, and Doshi JA
- Abstract
Background: Prior studies of the Medicare Part D coverage gap are limited in generalizability and scope. Objective: To determine the effect of the coverage gap on drugs used for asymptomatic (antihypertensive and lipid-lowering drugs) and symptomatic (pain relievers, acid suppressants, and antidepressants) conditions in elderly patients with hypertension and hyperlipidemia. Design: Quasi-experimental study using pre-post design and contemporaneous control group. Setting: Medicare claims files from 2005 and 2006 for 5% random sample of Medicare beneficiaries. Patients: Part D plan enrollees with hypertension or hyperlipidemia aged 65 years or older who had no coverage, generic-only coverage, or both brand-name and generic coverage during the gap in 2006. Patients who were fully eligible for the low-income subsidy served as the control group. Measurements: Monthly 30-day supply prescriptions available, medication adherence, and continuous medication gaps of 30 days or more for antihypertensive or lipid-lowering drugs; monthly 30-day supply prescriptions available for pain relievers, acid suppressants, or antidepressants before and after coverage gap entry. Results: Patients with no gap coverage had a decrease in monthly antihypertensive and lipid-lowering drug prescriptions during the coverage gap. Nonadherence also increased in this group (antihypertensives: odds ratio [OR], 1.60 [95% CI, 1.50 to 1.71]; lipid-lowering drugs: OR, 1.59 [CI, 1.50 to 1.68]). The proportion of patients with no gap coverage who had continuous medication gaps in lipid-lowering medication use and antihypertensive use increased by an absolute 7.3% (OR, 1.38 [CI, 1.29 to 1.46]) and 3.2% (OR, 1.35 [CI, 1.25 to 1.45]), respectively, because of the coverage gap. Decreases in use were smaller for pain relievers and antidepressants and larger for acid suppressants in patients with no gap coverage. Patients with generic-only coverage had decreased use of cardiovascular medications but no change in use of drugs for symptomatic conditions. No measures changed in the brand-name and generic coverage groups. Results of sensitivity analyses were consistent with the main findings. Limitation: Because this study was nonrandomized, unobserved differences may still exist between study groups. Conclusion: The Part D coverage gap was associated with decreased use of medications for hypertension and hyperlipidemia in patients with no gap coverage and generic-only gap coverage. The proposed phasing out of the gap by 2020 will benefit such patients; however, use of low-value medications may also increase. Primary Funding Source: Penn-Pfizer Alliance and American Heart Association. [ABSTRACT FROM AUTHOR]
- Published
- 2012
19. Can we reliably benchmark health technology assessment organizations?
- Author
-
Drummond M, Neumann P, Jönsson B, Luce B, Schwartz JS, Siebert U, and Sullivan SD
- Published
- 2012
20. The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.
- Author
-
Gray, SW, Hornik, RC, Schwartz, JS, and Armstrong, K
- Subjects
HUMAN chromosome abnormality diagnosis ,CONTROL groups ,CONSUMER behavior ,HEALTH risk assessment ,WOMEN'S health ,GENETIC mutation ,BRCA genes - Abstract
Gray SW, Hornik RC, Schwartz JS, Armstrong K. The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations. Despite an increase in direct-to-consumer (DTC) genetic testing, little is known about how variations in website content might alter consumer behavior. We evaluated the impact of risk information provision on women's attitudes about DTC BRCA testing. We conducted a randomized experiment; women viewed a 'mock' BRCA testing website without [control group (CG)] or with information on the potential risks of DTC testing [RG; framed two ways: unattributed risk (UR) information and risk information presented by experts (ER)]. Seven hundred and sixty-seven women participated; mean age was 37 years, mean education was 15 years, and 79% of subjects were white. Women in the RG had less positive beliefs about DTC testing (mean RG = 23.8,CG = 25.2;p = 0.001), lower intentions to get tested (RG = 2.8,CG = 3.1;p = 0.03), were more likely to prefer clinic-based testing (RG = 5.1,CG = 4.8;p = 0.03) and to report that they had seen enough risk information (RG = 5.3,CG = 4.7;p < 0.001). UR and ER exposure produced similar effects. Effects did not differ for women with or without a personal/family history of breast/ovarian cancer. Exposing women to the potential risks of DTC BRCA testing altered their beliefs, preferences, and intentions. Risk messages appear to be salient to women irrespective of their chance of having a BRCA mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
21. Patient-clinician information engagement increases treatment decision satisfaction among cancer patients through feeling of being informed.
- Author
-
Martinez LS, Schwartz JS, Freres D, Fraze T, Hornik RC, Martinez, Lourdes S, Schwartz, J Sanford, Freres, Derek, Fraze, Taressa, and Hornik, Robert C
- Abstract
Objective: Examine how patient-clinician information engagement (PCIE) may operate through feeling informed to influence patients' treatment decision satisfaction (TDS).Methods: Randomly drawn sample (N=2013) from Pennsylvania Cancer Registry, comprised of breast, prostate and colon cancer patients completed mail surveys in the Fall of 2006 (response rate=64%) and Fall of 2007. Of 2013 baseline respondents, 85% agreed to participate in follow-up survey (N=1703). Of those who agreed, 76% (N=1293) completed follow-up surveys. The sample was split between males and females. The majority of participants were White, over the age of 50, married, and with a high school degree. Most reported having been diagnosed with in situ and local cancer.Results: PCIE was related to concurrent TDS (beta=.06) and feeling informed (beta=.15), after confounder adjustments. A mediation analysis was consistent with PCIE affecting TDS through feeling informed. Baseline PCIE predicted feeling informed (beta=.04) measured 1 year later, after adjustments for baseline feeling informed and other confounders. Feeling informed was related to concurrent TDS (beta=.35) after confounder adjustment and follow-up TDS (beta=.13) after baseline TDS and confounder adjustment.Conclusion: Results suggest PCIE affects TDS in part through patients' feeling informed.Practice Implications: PCIE may be important in determining patients' level of feeling informed and TDS. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
22. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?
- Author
-
Agarwal S, Tang SS, Rosenberg N, Pettitt D, McLaughlin T, Joyce A, and Schwartz JS
- Published
- 2009
- Full Text
- View/download PDF
23. Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.
- Author
-
Guerra CE, Gimotty PA, Shea JA, Pagán JA, Schwartz JS, and Armstrong K
- Abstract
BACKGROUND: Little is known about the effect of guidelines that recommend shared decision making on physician practice patterns. The objective of this study was to determine the association between physicians' perceived effect of guidelines on clinical practice and self-reported prostate-specific antigen (PSA) screening patterns. METHODS: This was a cross-sectional study using a nationally representative sample of 3914 primary care physicians participating in the 1998-1999 Community Tracking Study Physician Survey. Responses to a case vignette that asked physicians what proportion of asymptomatic 60-year-old white men they would screen with a PSA were divided into 3 distinct groups: consistent PSA screeners (screen all), variable screeners (screen 1%- 99%), and consistent nonscreeners (screen none). Logistic regression was used to determine the association between PSA screening patterns and physician-reported effect of guidelines (no effect v. any magnitude effect). RESULTS: Only 27% of physicians were variable PSA screeners; the rest were consistent screeners (60%) and consistent nonscreeners (13%). Only 8% of physicians perceived guidelines to have no effect on their practice. After adjustment for demographic and practice characteristics, variable screeners were more likely to report any magnitude effect of guidelines on their practice when compared with physicians in the other 2 groups (adjusted odds ratio= 1.73; 95% confidence interval=1:25-2:38;P=0:001). CONCLUSIONS: Physicians who perceive an effect of guidelines on their practice are almost twice as likely to exhibit screening PSA practice variability, whereas physicians who do not perceive an effect of guidelines on their practice are more likely to be consistent PSA screeners or consistent PSA nonscreeners. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
24. Nonfinancial incentives for quality: a policy statement from the American Heart Association.
- Author
-
Bufalino V, Peterson ED, Krumholz HM, Burke GL, LaBresh KA, Jones DW, Faxon DP, Valadez AM, Solis P, Schwartz JS, and American Heart Association
- Published
- 2007
25. Payment for quality: guiding principles and recommendations: principles and recommendations from the American Heart Association's Reimbursement, Coverage, and Access Policy Development Workgroup.
- Author
-
Bufalino V, Peterson ED, Burke GL, LaBresh KA, Jones DW, Faxon DP, Valadez AM, Brass LM, Fulwider VB, Smith R, Krumholz HM, Schwartz JS, and American Heart Association. Reimbursement, Coverage, and Access Policy Development Workgroup
- Published
- 2006
26. Physician attitudes regarding cardiovascular risk reduction: the gaps between clinical importance, knowledge, and effectiveness.
- Author
-
Castaldo J, Nester J, Wasser T, Masiado T, Rossi M, Young M, Napolitano JJ, and Schwartz JS
- Abstract
Reducing risk factors for patients with vascular disease can reduce the subsequent incidence of cerebro-cardiovascular disease. While physicians have had extensive training in the importance of atherosclerotic vascular disease risk factor modification, evidence suggests that they systematically miss opportunities for clinical prevention during routine practice. The aim of this study was to identify whether physicians felt confident in their knowledge and effectiveness regarding counseling patients to reduce cardiovascular risk and to determine barriers to prevention interventions in the office setting. Surveys were mailed to 509 physicians affiliated with an academic community hospital. Nonrespondents were sent reminders and a second survey. Comparisons were made using chi-square analysis. Two hundred and five surveys were returned (40.3%). Thirty-six percent of physicians felt knowledgeable about weight management techniques, compared to 3% who were confident that they succeeded in their practice (p < 0.001). Similar patterns were found for Tobacco Cessation (62% versus 14%, p = 0.001), Alcohol Reduction (46% versus 7%, p < 0.001), Stress Management (35% versus 5%, p < 0.001), Exercise (53% versus 10%, p < 0.001), Nutrition (36% versus 8%, p < 0.001), Diabetes Management (48% versus 23%, p < 0.001), Blood Pressure Management (57% versus 43%, p < 0.001) and Lipid Management (59% versus 38%, p < 0.001). We identified a significant gap between physician confidence in their knowledge about risk factors and their effectiveness at providing counseling and obtaining results in their office. Most physicians felt that the routine office follow-up visit was an ineffective method for instituting vascular risk factor reduction. Alternate settings for risk factor reduction may be needed for improving atherosclerosis prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
27. The financial burden of emergency department congestion and hospital crowding for chest pain patients awaiting admission.
- Author
-
Bayley MD, Schwartz JS, Shofer FS, Weiner M, Sites FD, Traber KB, Hollander JE, Bayley, Matthew D, Schwartz, J Sanford, Shofer, Frances S, Weiner, Mark, Sites, Frank D, Traber, K Bobbi, and Hollander, Judd E
- Abstract
Study Objective: We determined the additional cost of an extended emergency department (ED) length of stay for chest pain patients awaiting non-ICU, monitored (telemetry) beds.Methods: This was a prospective cohort study of all ED chest pain patients aged 24 years or older and admitted to a telemetry bed in an urban university hospital during a 12-month period. Structured ED data collection included demographics, chest pain presentation, medical history, and laboratory test and ECG results. Hospital course was monitored daily, followed by a 30-day telephone follow-up. Risk severity scores (Goldman, Acute Cardiac Ischemia-Time-Insensitive Predictive Instrument, and Charlson) were calculated. Hospital charges, real costs, and revenues were obtained at discharge and 2 years later. The main outcome measure was risk-adjusted additional cost to the hospital of a delayed ED admission. Clinical outcome was a secondary measure.Results: Of the 817 patients with chest pain presenting to the ED during the study period, there were 904 hospitalizations. Of these, 825 patients waited more than 3 hours for their bed (91%). There were 21 patient visits with a final diagnosis of acute myocardial infarction. ED length of stay was not associated with total hospital length of stay (r =0.01), hospital costs, or hospital or professional charges, revenues, or collection rates. The annual opportunity cost in lost hospital revenue for chest pain patients was 168,300 US dollars (204 US dollars per patient waiting >3 hours for a hospital bed).Conclusion: Extended ED length of stay demonstrated no association with total hospital costs or revenues or total hospital length of stay but imposed substantial ED opportunity costs, with decreased potential revenue. Interventions that reduce ED delays in hospital admissions have the potential to significantly increase hospital revenues. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
28. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial [corrected] [published erratum appears in J AM GERIATR SOC 2004 Jul;52(7):1228].
- Author
-
Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, and Schwartz JS
- Abstract
OBJECTIVES: To examine the effectiveness of a transitional care intervention delivered by advanced practice nurses (APNs) to elders hospitalized with heart failure. DESIGN: Randomized, controlled trial with follow-up through 52 weeks postindex hospital discharge. SETTING: Six Philadelphia academic and community hospitals. PARTICIPANTS: Two hundred thirty-nine eligible patients were aged 65 and older and hospitalized with heart failure. INTERVENTION: A 3-month APN-directed discharge planning and home follow-up protocol. MEASUREMENTS: Time to first rehospitalization or death, number of rehospitalizations, quality of life, functional status, costs, and satisfaction with care. RESULTS: Mean age of patients (control n=121; intervention n=118) enrolled was 76; 43% were male, and 36% were African American. Time to first readmission or death was longer in intervention patients (log rank chi(2)=5.0, P=.026; Cox regression incidence density ratio=1.65, 95% confidence interval=1.13-2.40). At 52 weeks, intervention group patients had fewer readmissions (104 vs 162, P=.047) and lower mean total costs ($7,636 vs $12,481, P=.002). For intervention patients, only short-term improvements were demonstrated in overall quality of life (12 weeks, P<.05), physical dimension of quality of life (2 weeks, P<.01; 12 weeks, P<.05) and patient satisfaction (assessed at 2 and 6 weeks, P<.001). CONCLUSION: A comprehensive transitional care intervention for elders hospitalized with heart failure increased the length of time between hospital discharge and readmission or death, reduced total number of rehospitalizations, and decreased healthcare costs, thus demonstrating great promise for improving clinical and economic outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
29. Relationship of pulmonary artery catheter to use mortality and resource utilization in patients with severe sepsis.
- Author
-
Yu DT, Platt R, Lanken PN, Black E, Sands KE, Schwartz JS, Hibberd PL, Graman PS, Kahn KL, Snydman DR, Parsonnet J, Moore R, Bates DW, and AMCC Sepsis Project Working Group
- Published
- 2003
30. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
- Author
-
Armstrong K, Chen T, Albert D, Randall TC, Schwartz JS, Armstrong, K, Chen, T M, Albert, D, Randall, T C, and Schwartz, J S
- Published
- 2001
- Full Text
- View/download PDF
31. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
- Author
-
Naylor MD, Brooten D, Campbell R, Jacobsen BS, Mezey MD, Pauly MV, Schwartz JS, Naylor, M D, Brooten, D, Campbell, R, Jacobsen, B S, Mezey, M D, Pauly, M V, and Schwartz, J S
- Abstract
Context: Comprehensive discharge planning by advanced practice nurses has demonstrated short-term reductions in readmissions of elderly patients, but the benefits of more intensive follow-up of hospitalized elders at risk for poor outcomes after discharge has not been studied.Objective: To examine the effectiveness of an advanced practice nurse-centered discharge planning and home follow-up intervention for elders at risk for hospital readmissions.Design: Randomized clinical trial with follow-up at 2, 6, 12, and 24 weeks after index hospital discharge.Setting: Two urban, academically affiliated hospitals in Philadelphia, Pa.Participants: Eligible patients were 65 years or older, hospitalized between August 1992 and March 1996, and had 1 of several medical and surgical reasons for admission.Intervention: Intervention group patients received a comprehensive discharge planning and home follow-up protocol designed specifically for elders at risk for poor outcomes after discharge and implemented by advanced practice nurses.Main Outcome Measures: Readmissions, time to first readmission, acute care visits after discharge, costs, functional status, depression, and patient satisfaction.Results: A total of 363 patients (186 in the control group and 177 in the intervention group) were enrolled in the study; 70% of intervention and 74% of control subjects completed the trial. Mean age of sample was 75 years; 50% were men and 45% were black. By week 24 after the index hospital discharge, control group patients were more likely than intervention group patients to be readmitted at least once (37.1 % vs 20.3 %; P<.001). Fewer intervention group patients had multiple readmissions (6.2% vs 14.5%; P = .01) and the intervention group had fewer hospital days per patient (1.53 vs 4.09 days; P<.001). Time to first readmission was increased in the intervention group (P<.001). At 24 weeks after discharge, total Medicare reimbursements for health services were about $1.2 million in the control group vs about $0.6 million in the intervention group (P<.001). There were no significant group differences in post-discharge acute care visits, functional status, depression, or patient satisfaction.Conclusions: An advanced practice nurse-centered discharge planning and home care intervention for at-risk hospitalized elders reduced readmissions, lengthened the time between discharge and readmission, and decreased the costs of providing health care. Thus, the intervention demonstrated great potential in promoting positive outcomes for hospitalized elders at high risk for rehospitalization while reducing costs. [ABSTRACT FROM AUTHOR]- Published
- 1999
- Full Text
- View/download PDF
32. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
- Author
-
Sonnenberg A, Schwartz JS, Cutler AF, Vakil N, and Bloom BS
- Published
- 1998
- Full Text
- View/download PDF
33. Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system.
- Author
-
Schwartz JS, Kinosian BP, Pierskalla WP, Lee H, Schwartz, J S, Kinosian, B P, Pierskalla, W P, and Lee, H
- Abstract
A decision analytic model was used to examine alternative strategies to screen donated blood for human immunodeficiency virus (HIV) using data from the literature and from 1987 blood-screening programs in areas with high and low prevalence of HIV. Sensitivity analyses incorporated uncertainties about HIV infection and test performance. Current screening strategies are estimated to allow 20.5 infected units per million donated units to be transfused at a cost of $16,850 per HIV-positive unit detected in high-prevalence areas and 4.7 infected units per million donated units to be transfused at a cost of $32,275 per HIV-positive unit detected in low prevalence areas, with nine false-positive notifications of uninfected patients per million units screened and 14.9 discarded, noninfected units per HIV-positive unit in low-prevalence areas. Testing donated blood for HIV can be improved by individualizing screening strategies for areas with different prevalences of HIV. Efforts to further reduce transfusion-associated HIV should focus on improved test performance in early stages of infection, reduction of unnecessary transfusions, donor recruitment in lower-risk groups, and public health measures to reduce HIV infection among the general population. [ABSTRACT FROM AUTHOR]
- Published
- 1990
- Full Text
- View/download PDF
34. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery.
- Author
-
Silber JH, Rosenbaum PR, Schwartz JS, Ross RN, Williams SV, Silber, J H, Rosenbaum, P R, Schwartz, J S, Ross, R N, and Williams, S V
- Abstract
Objective: To determine whether hospital rankings based on complication rates provide the same information as hospital rankings based on mortality rates.Design: A retrospective study of in-hospital death, complication, and death following complication (failure to rescue). Hospitals were ranked using residuals based on the difference between the observed and the expected number of events (from logistic regression models); rankings were compared using Spearman rank correlations.Setting: Hospitals performing coronary artery bypass graft (CABG) surgery in the 1991 and 1992 MedisGroups National Comparative Data Bases. PATIENTS AND DATA SETS: Record abstraction data for 16,673 patients who underwent CABG procedures at 57 hospitals, linked with data from the 1991 American Hospital Association Annual Survey.Results: After adjusting for patient admission severity of illness, there were low correlations between hospital rankings based on death or failure to rescue and those rankings based on complication (death vs complication, r = 0.07, P = .58; failure to rescue vs complication, r = -0.22, P = .11). In addition, many hospital characteristics that are generally associated with a higher quality of care were associated with higher complication rates but with expected or lower-than-expected mortality rates.Conclusions: Hospital rankings based on complication rates provide different information than those based on mortality rates. Until more is known about these differences, complication rates should not be used to judge hospital quality of care in CABG surgery. [ABSTRACT FROM AUTHOR]- Published
- 1995
- Full Text
- View/download PDF
35. The appropriateness of coronary artery bypass graft surgery in academic medical centers. Working Group of the Appropriateness Project of the Academic Medical Center Consortium.
- Author
-
Leape LL, Hilborne LH, Schwartz JS, Bates DW, Rubin HR, Slavin P, Park RE, Witter DM Jr., Panzer RJ, Brook RH, Working Group of the Appropriateness Project of the Academic Medical Center Consortium, Leape, L L, Hilborne, L H, Schwartz, J S, Bates, D W, Rubin, H R, Slavin, P, Park, R E, Witter, D M Jr, and Panzer, R J
- Abstract
Objective: To compare the appropriateness of use of coronary artery bypass graft (CABG) surgery in Academic Medical Center Consortium hospitals as judged 1) according to criteria developed by an expert panel, 2) according to revisions of those criteria made by cardiac surgeons from the Academic Medical Center Consortium, and 3) by review of cases by the surgeons responsible for those cases.Design: Retrospective, randomized medical record review.Setting: 12 Academic Medical Center Consortium hospitals.Patients: Random sample of 1156 patients who had had isolated CABG surgery in 1990.Main Outcome Measures: 1) Percentage of patients with indications for which CABG surgery was classified as appropriate, Inappropriate, or of uncertain appropriateness and 2) percentage of cases in which CABG surgery was judged inappropriate or uncertain for which ratings changed after local case review.Results: Data were retrieved from medical records by trained abstractors using an explicit data collection instrument. Cases in which CABG surgery was judged to be inappropriate or uncertain were individually reviewed by the responsible surgeons. According to the expert panel ratings, 83% of the CABG operations (95% CI, 81% to 85%) were necessary, 9% (CI, 8% to 10%) were appropriate, 7% (CI, 5% to 8%) were uncertain, and 1.6% (CI, 0.6% to 2.5%) were inappropriate. These rates are almost identical to those found in a previous study that was done in New York State and that used the same criteria (in that study, 91% of operations were classified as necessary or appropriate, 7% were classified as uncertain, and 2.4% were classified as inappropriate). Rates of inappropriate procedures varied from 0% to 5% among the 12 member hospitals (P = 0.02). The Academic Medical Center Consortium cardiac surgeons revised 568 (24%) of the indications used by the expert panel. However, because those revisions altered the appropriateness ratings in both directions and affected only 50 cases (4%), the net effect of the revisions was slight: The rate of inappropriate CABG surgery increased from 1.6% to 1.9%. Local review found that data collection errors had caused erroneous ratings in 12.5% of 64 cases in which surgery had been classified as inappropriate or uncertain.Conclusions: The Academic Medical Center Consortium hospitals had low rates of inappropriate and uncertain use of CABG surgery, regardless of the criteria used for assessment. Even though surgeons from the Consortium revised the appropriateness ratings extensively, their revisions had a negligible effect on the overall assessment of appropriateness. However, because of potential data collection errors, appropriateness criteria should be used for individual case audits only if supplemented by subsequent physician review. [ABSTRACT FROM AUTHOR]- Published
- 1996
- Full Text
- View/download PDF
36. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.
- Author
-
Magid D, Douglas JM Jr., Schwartz JS, Magid, D, Douglas, J M Jr, and Schwartz, J S
- Abstract
Objective: To compare the economic consequences of doxycycline therapy with those of azithromycin therapy for women with uncomplicated cervical chlamydial infections.Design: Decision analysis in which the health outcomes, costs, and cost-effectiveness of two provider-administered treatment strategies for women with uncomplicated cervical chlamydial infections were compared: 1) initial therapy with doxycycline, 100 mg orally twice daily for 7 days (estimated cost, $5.51) and 2) initial therapy with azithromycin, 1 g orally administered as a single dose (estimated cost, $18.75).Results: Under baseline assumptions, the azithromycin strategy incurred fewer major and minor complications and was less expensive overall than the doxycycline strategy despite a higher initial cost for acquiring antibiotic agents. In univariate sensitivity analyses, the azithromycin strategy prevented more major complications but was more expensive than the doxycycline strategy when doxycycline effectiveness was greater than 0.93. In a multivariate sensitivity analysis combining 11 parameter estimates selected so that the cost-effectiveness of the doxycycline strategy would be maximized relative to that of the azithromycin strategy, the azithromycin strategy resulted in fewer complications but was more costly. The incremental cost-effectiveness was $521 per additional major complication prevented. However, if the difference in the cost of azithromycin and doxycycline decreased to $9.80, the azithromycin strategy was less expensive and more effective, even under these extreme conditions.Conclusions: On the basis of the best available data as derived from the literature and experts, the azithromycin strategy was more cost-effective than the doxycycline strategy for women with uncomplicated cervical chlamydial infections. Despite the dominance of the azithromycin strategy over the doxycycline strategy, the adoption of the azithromycin strategy may be limited by the practical financial constraints of our currently fragmented health care system, in which the costs and benefits of preventing chlamydia sequelae are often incurred by different components of the system. [ABSTRACT FROM AUTHOR]- Published
- 1996
- Full Text
- View/download PDF
37. Primary Prevention of Coronary Heart Disease With Statins: It's Not About the Money.
- Author
-
Schwartz JS
- Published
- 2011
- Full Text
- View/download PDF
38. Letter to the editor
- Author
-
Bove Aa, Santamore Wp, and Schwartz Js
- Subjects
medicine.medical_specialty ,Blood pressure ,business.industry ,Internal medicine ,Cardiology ,Medicine ,Blood flow ,Coronary disease ,Cardiology and Cardiovascular Medicine ,business - Published
- 1986
- Full Text
- View/download PDF
39. Performance of an index predicting the response of patients with acute bronchial asthma to intensive emergency department treatment
- Author
-
Christopher C. Rose, Jane G Murphy, and Schwartz Js
- Subjects
Analysis of Variance ,Index (economics) ,business.industry ,Respiration ,Peak Expiratory Flow Rate ,General Medicine ,Emergency department ,Hospital Bed Capacity, 500 and over ,medicine.disease ,Prognosis ,humanities ,Asthma ,respiratory tract diseases ,Physician visit ,Patient Admission ,medicine ,Humans ,Medical emergency ,business ,Emergency Service, Hospital ,Pulse - Abstract
IT is estimated that acute bronchial asthma accounts for 134,000 hospital admissions and 27 million physician visits annually in the United States.1 Physicians practicing in emergency departments h...
- Published
- 1984
40. The adoption and diffusion of CT and MRI in the United States. A comparative analysis
- Author
-
Hillman Al and Schwartz Js
- Subjects
medicine.medical_specialty ,MRI diffusion ,Magnetic Resonance Spectroscopy ,Technology Assessment, Biomedical ,Time Factors ,Certificate of need ,Medicare ,Reimbursement Mechanisms ,Premarket Approval ,Medicine ,Humans ,Medical physics ,Diffusion (business) ,Reimbursement ,Marketing of Health Services ,Economic Competition ,medicine.diagnostic_test ,Certificate of Need ,business.industry ,Prospective Payment System ,Communication ,Health Policy ,Public Health, Environmental and Occupational Health ,Magnetic resonance imaging ,United States ,Costs and Cost Analysis ,Prospective payment system ,Tomography ,Diffusion of Innovation ,business ,Tomography, X-Ray Computed - Abstract
This study examines and compares the rates and patterns of diffusion of computerized tomography (CT) and magnetic resonance imaging (MRI) over the first 4 years of their availability. Although early diffusion of CT was more rapid than that of MRI, adoption of MRI in nonhospital settings equaled that of CT. Analysis of attributes of the technologies and attributes of the regulatory, reimbursement, and market environments surrounding the early diffusion of these technologies provides insight into their different diffusion patterns. In particular, the technical and financial uncertainties surrounding MRI have inhibited its diffusion compared with that of CT. Medicare's DRG-based prospective reimbursement system and certificate-of-need (CON) regulation by states have reduced overall MRI diffusion and stimulated purchases of MRI by nonhospital organizations. The FDA's premarket approval (PMA) program has changed marketing strategies and influenced the diffusion of MRI to a lesser degree. This analysis identifies problems in how the present health care system evaluates and adopts new, expensive, diagnostic technologies and suggests changes to make the system more responsive to present needs.
- Published
- 1985
41. Pneumococcal vaccine: clinical efficacy and effectiveness
- Author
-
Schwartz Js
- Subjects
Serotype ,Adult ,Risk ,Cost-Benefit Analysis ,Postmarketing surveillance ,Anemia, Sickle Cell ,medicine.disease_cause ,Polysaccharide Vaccine ,Pneumococcal Infections ,Pneumococcal Vaccines ,Streptococcus pneumoniae ,Internal Medicine ,medicine ,Humans ,Child ,Aged ,Immunosuppression Therapy ,Clinical Trials as Topic ,business.industry ,Incidence (epidemiology) ,Polysaccharides, Bacterial ,Vaccination ,Age Factors ,General Medicine ,Pneumonia, Pneumococcal ,Antibodies, Bacterial ,Hodgkin Disease ,United States ,Clinical trial ,Pneumococcal vaccine ,Immunology ,Bacterial Vaccines ,Chronic Disease ,business - Abstract
Streptococcus pneumoniae causes substantial morbidity and mortality. Incidence and severity are increased among populations with some chronic diseases. The currently available polyvalent polysaccharide vaccine induces antibody production among immunologically competent recipients against the 14 serotypes responsible for 80% of pneumococcal bacteremia in the efficacious in clinical trials with healthy young men in epidemic conditions and in patient with sickle cell anemia. Similar trials in two other high-risk populations had inconclusive results. Decisions on vaccine use now largely rest on indirect evidence of efficacy derived from knowledge of disease incidence, severity, and antibody response to vaccination among patient groups. Findings of a literature review suggest vaccinating high-risk patients immunologically competent to produce homotypic antibodies in response to vaccination with polysaccharide antigen, while continuing investigation of disease incidence, severity, serotype distribution, and immunologic response among high-risk groups and postmarketing surveillance efforts among all vaccinated patients.
- Published
- 1982
42. The diffusion of MRI: patterns of siting and ownership in an era of changing incentives
- Author
-
Hillman, AL, primary and Schwartz, JS, additional
- Published
- 1986
- Full Text
- View/download PDF
43. Routine Use of the Prothrombin and Partial Thromboplastin Times
- Author
-
Schwartz Js, Kinman Jl, and Stephen Erban
- Subjects
Prothrombin time ,Blue shield ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Hospitalized patients ,General Medicine ,Teaching hospital ,Surgery ,comic_books ,Emergency medicine ,Medicine ,Thromboplastin ,business ,comic_books.character ,circulatory and respiratory physiology ,Partial thromboplastin time - Abstract
The prothrombin time (PT) and activated partial thromboplastin time (APTT) tests are often routinely ordered for hospitalized patients. Ordering patterns and clinical indications for the PT and APTT tests on the medical service at a teaching hospital were studied. Eighty-one percent of all patients admitted to the medical service had a PT and APTT test ordered. When compared with a modified version of guidelines for the use of the PT and APTT tests recently developed by the Medical Necessity Project of the Blue Cross and Blue Shield Associations of America and endorsed by the American College of Physicians, at least 70% of these tests were not clinically indicated. Many of the unindicated tests were ordered prior to invasive procedures or, apparently, out of habit. These inappropriate PT and APTT tests cost at least $60 948 per year for the medical service. Based on these findings, we suggest methods of reducing the inappropriate use of the PT and APTT tests. ( JAMA . 1989;262:2428-2432)
- Published
- 1989
- Full Text
- View/download PDF
44. The role of dissolved organic carbon in Great Smoky Mountains National Park streams impacted by long-term acid deposition.
- Author
-
Brown JR, Schwartz JS, Essington ME, He Q, Kulp MA, and Simpson IM
- Subjects
- Acid Rain, Seasons, Environmental Monitoring, Rivers chemistry, Carbon analysis, Water Pollutants, Chemical analysis, Parks, Recreational
- Abstract
Following reductions in acid deposition in the Great Smoky Mountains National Park (GRSM) since the 2000s, many streams remain acidic and the role of organic acids (OA
- ) remains unknown due to limited OA- data. This study investigated dissolved organic carbon (DOC) concentrations as a surrogate for OA- across GRSM and its relationships with watershed characteristics, seasons, flow, and stream chemistry. Baseflow water samples were collected from seven watersheds for 2 years and stormflow samples from three watersheds for 1 year. During baseflow, DOC concentrations ranged from < 0.04 to 2.29 mg L-1 with watershed medians between 0.61 and 1.00 mg L-1 . Stormflow DOC concentrations ranged from 1.36 to 5.66 mg L-1 . During the summer, median DOC concentrations were about twice that of the other three seasons. Stream DOC concentrations decreased with increasing elevation during baseflow but increased with increasing elevation during stormflow. Considering high elevations historically received greater acid deposition, this gradient between baseflow and stormflow suggests higher elevation streams are more impacted by OA- . Based on an OA- /DOC acidity model, it was estimated that during baseflow OA- was a minor contributor to stream acidity, in the order of 5.3 μeq L-1 , however stormflow OA- was estimated at 52.5 μeq L-1 , contributing to nearly half of stream acidity. Baseflow DOC was significantly correlated with pH and Ca2+ , suggesting stream acidification/recovery is governed by base cations and Ca2+ availability. Furthermore, this study provides essential data for future research to evaluate stream DOC trends during acidification recovery and changes in biogeochemical processes., (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)- Published
- 2024
- Full Text
- View/download PDF
45. Outcomes of SADI and OAGB Compared to RYGB from the Metabolic and Bariatric Surgery Quality Improvement Program: The North American Experience.
- Author
-
Chao GF, Canner J, Hamid S, Ying LD, Ghiassi S, Schwartz JS, and Gibbs KE
- Subjects
- Humans, Quality Improvement, Gastrectomy methods, North America epidemiology, Retrospective Studies, Treatment Outcome, Gastric Bypass methods, Obesity, Morbid surgery, Bariatric Surgery
- Abstract
Background: Rapid adoption of sleeve gastrectomy (SG) in the last decade aptly reflects the desire of patients and surgeons for alternatives to RYGB and DS. While SG provides good outcomes, other options that address specific patient needs are warranted. Recently approved by ASMBS, SADI, and OAGB have garnered increasing interest due to their single anastomosis technique., Methods: Using the Metabolic and Bariatric Surgery Quality Improvement Program database, we examined laparoscopic and robotic cases from 2018 to 2021 to understand the percentage of primary bariatric surgery cases that are SADI and OAGB. We used coarsened exact matching to match patients who underwent SADI or OAGB to patients who underwent Roux-en-Y gastric bypass (RYGB). We examined outcomes of matched patients using logistic regression., Results: Of the 667,979 patients that underwent bariatric-metabolic surgery, 1326 (0.2%) underwent SADI, and 2541 (0.4%) underwent OAGB. SADI was not identified in the database until 2020. In 2020, there were 487 SADI procedures compared to 839 in 2021. From 2018 to 2021, OAGBs went from 149 to 940. Compared with RYGB, SADI was associated with higher rates of anastomotic or staple line leak (OR 2.21 (95% CI 1.08-4.53)) and sepsis (OR 3.62 (95% CI 1.62-8.12)). Compared with RYGB, OAGB was associated with lower rates of gastrointestinal bleeding (OR 0.29 (95% CI 0.12-0.71)) and bowel obstruction (OR 0.10 (95% CI 0.02-0.39)). Of note, there were no differences between these procedures and RYGB for 30-day mortality., Conclusion: More SADIs and OAGBs are being performed. However, there were higher complication rates associated with the SADI procedure. Further studies will be needed to better understand the key drivers for these outcomes., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
46. The Degree of Preoperative Hypoalbuminemia Is Associated with Risk of Postoperative Complications in Metabolic and Bariatric Surgery Patients.
- Author
-
Ying LD, Chao GF, Canner J, Graetz E, Ghiassi S, Schwartz JS, Zolfaghari EJ, Schneider EB, and Gibbs KE
- Subjects
- Humans, Postoperative Complications etiology, Gastrectomy adverse effects, Gastrectomy methods, Retrospective Studies, Treatment Outcome, Hypoalbuminemia epidemiology, Hypoalbuminemia etiology, Obesity, Morbid surgery, Bariatric Surgery adverse effects, Bariatric Surgery methods, Gastric Bypass methods
- Abstract
Background: The incidence and impact of hypoalbuminemia in bariatric surgery patients is poorly characterized. We describe its distribution in laparoscopic sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB) patients undergoing primary or revision surgeries and assess its impact on postoperative complications., Methods: The Metabolic and Bariatric Surgery Quality Improvement Program Database (2015 to 2021) was analyzed. Hypoalbuminemia was defined as Severe (< 3 g/dL), Moderate (3 ≤ 3.5 g/dL), Mild (3.5 ≤ 4 g/dL), or Normal (≥ 4 g/dL). Multivariable logistic regression was performed to calculate odds ratios of postoperative complications compared to those with Normal albumin after controlling for procedure, age, gender, race, body mass index, functional status, American Society of Anesthesia class, and operative length., Results: A total of 817,310 patients undergoing Primary surgery and 69,938 patients undergoing Revision/Conversion ("Revision") surgery were analyzed. The prevalence of hypoalbuminemia was as follows (Primary, Revision): Severe, 0.3%, 0.6%; Moderate, 5.2%, 6.5%; Mild, 28.3%, 31.4%; Normal, 66.2%, 61.4%. Primary and Revision patients with hypoalbuminemia had a significantly higher prevalence (p < 0.01) of several co-morbidities, including hypertension and insulin-dependent diabetes. Any degree of hypoalbuminemia increased the odds ratio of several complications in Primary and Revision patients, including readmission, intervention, and reoperation. In Primary patients, all levels of hypoalbuminemia also increased the odds ratio of unplanned intubation, intensive care unit admission, and venous thromboembolism requiring therapy., Conclusion: Over 30% of patients present with hypoalbuminemia. Even mild hypoalbuminemia was associated with an increased rate of several complications including readmission, intervention, and reoperation. Ensuring nutritional optimization, especially prior to revision surgery, may improve outcomes in this challenging population., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
47. Environmental regulations in the United States lead to improvements in untreated stormwater quality over four decades.
- Author
-
Simpson IM, Schwartz JS, Hathaway JM, and Winston RJ
- Subjects
- United States, Lead, Zinc analysis, Phosphorus, Environmental Monitoring methods, Rain, Water Movements, Water Pollutants, Chemical analysis, Environmental Pollutants
- Abstract
Identifying sources of pollutants in watersheds is critical to accurately predicting stormwater quality. Many existing software used to model stormwater quality rely on decades-old data sets which may not represent current runoff quality in the United States. Because of environmental regulations promulgated at the federal level over previous decades, there is a need to understand long-term trends (and potential shifts) in runoff quality to better parameterize models. Pollutant event mean concentrations (EMCs) from the National Stormwater Quality Database (NSQD) were combined with those from recent sources to understand if untreated stormwater quality has changed over the past 40 years. A significant decreasing monotonic trend (i.e., continually decreasing in a nonuniform fashion) was observed for total suspended solids (TSS), total phosphorus (TP), total Kjeldahl nitrogen (TKN), total copper (Cu), total lead (Pb), and total zinc (Zn) in the resultant database, suggesting that runoff quality has become less polluted with time. Median EMCs decreased from 99.2 to 42 mg/L, 0.34 to 0.26 mg/L, 1.27 to 1.03 mg/L, 40 to 6.8 µg/L, 110 to 3.7 µg/L, and 375 to 53.3 µg/L for TSS, TP, TN, Cu, Pb, and Zn, respectively, from the 1980s to the 2010s. These significant reductions often aligned temporally with advancements in clean manufacturing, amendments of the Clean Air Act, and other source control efforts which impact pollutant bioavailability and atmospheric deposition. Results suggest environmental regulations not specifically targeting stormwater management have had a positive impact on stormwater quality and that temporal fluctuations should be considered in modeling., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
48. Pain, Analgesic Use, and Patient Satisfaction With Spinal Versus General Anesthesia for Hip Fracture Surgery : A Randomized Clinical Trial.
- Author
-
Neuman MD, Feng R, Ellenberg SS, Sieber F, Sessler DI, Magaziner J, Elkassabany N, Schwenk ES, Dillane D, Marcantonio ER, Menio D, Ayad S, Hassan M, Stone T, Papp S, Donegan D, Marshall M, Jaffe JD, Luke C, Sharma B, Azim S, Hymes R, Chin KJ, Sheppard R, Perlman B, Sappenfield J, Hauck E, Hoeft MA, Tierney A, Gaskins LJ, Horan AD, Brown T, Dattilo J, Carson JL, Looke T, Bent S, Franco-Mora A, Hedrick P, Newbern M, Tadros R, Pealer K, Vlassakov K, Buckley C, Gavin L, Gorbatov S, Gosnell J, Steen T, Vafai A, Zeballos J, Hruslinski J, Cardenas L, Berry A, Getchell J, Quercetti N, Bajracharya G, Billow D, Bloomfield M, Cuko E, Elyaderani MK, Hampton R, Honar H, Khoshknabi D, Kim D, Krahe D, Lew MM, Maheshwer CB, Niazi A, Saha P, Salih A, de Swart RJ, Volio A, Bolkus K, DeAngelis M, Dodson G, Gerritsen J, McEniry B, Mitrev L, Kwofie MK, Belliveau A, Bonazza F, Lloyd V, Panek I, Dabiri J, Chavez C, Craig J, Davidson T, Dietrichs C, Fleetwood C, Foley M, Getto C, Hailes S, Hermes S, Hooper A, Koener G, Kohls K, Law L, Lipp A, Losey A, Nelson W, Nieto M, Rogers P, Rutman S, Scales G, Sebastian B, Stanciu T, Lobel G, Giampiccolo M, Herman D, Kaufman M, Murphy B, Pau C, Puzio T, Veselsky M, Apostle K, Boyer D, Fan BC, Lee S, Lemke M, Merchant R, Moola F, Payne K, Perey B, Viskontas D, Poler M, D'Antonio P, O'Neill G, Abdullah A, Fish-Fuhrmann J, Giska M, Fidkowski C, Guthrie ST, Hakeos W, Hayes L, Hoegler J, Nowak K, Beck J, Cuff J, Gaski G, Haaser S, Holzman M, Malekzadeh AS, Ramsey L, Schulman J, Schwartzbach C, Azefor T, Davani A, Jaberi M, Masear C, Haider SB, Chungu C, Ebrahimi A, Fikry K, Marcantonio A, Shelvan A, Sanders D, Clarke C, Lawendy A, Schwartz G, Garg M, Kim J, Caruci J, Commeh E, Cuevas R, Cuff G, Franco L, Furgiuele D, Giuca M, Allman M, Barzideh O, Cossaro J, D'Arduini A, Farhi A, Gould J, Kafel J, Patel A, Peller A, Reshef H, Safur M, Toscano F, Tedore T, Akerman M, Brumberger E, Clark S, Friedlander R, Jegarl A, Lane J, Lyden JP, Mehta N, Murrell MT, Painter N, Ricci W, Sbrollini K, Sharma R, Steel PAD, Steinkamp M, Weinberg R, Wellman DS, Nader A, Fitzgerald P, Ritz M, Bryson G, Craig A, Farhat C, Gammon B, Gofton W, Harris N, Lalonde K, Liew A, Meulenkamp B, Sonnenburg K, Wai E, Wilkin G, Troxell K, Alderfer ME, Brannen J, Cupitt C, Gerhart S, McLin R, Sheidy J, Yurick K, Chen F, Dragert K, Kiss G, Malveaux H, McCloskey D, Mellender S, Mungekar SS, Noveck H, Sagebien C, Biby L, McKelvy G, Richards A, Abola R, Ayala B, Halper D, Mavarez A, Rizwan S, Choi S, Awad I, Flynn B, Henry P, Jenkinson R, Kaustov L, Lappin E, McHardy P, Singh A, Donnelly J, Gonzalez M, Haydel C, Livelsberger J, Pazionis T, Slattery B, Vazquez-Trejo M, Baratta J, Cirullo M, Deiling B, Deschamps L, Glick M, Katz D, Krieg J, Lessin J, Mojica J, Torjman M, Jin R, Salpeter MJ, Powell M, Simmons J, Lawson P, Kukreja P, Graves S, Sturdivant A, Bryant A, Crump SJ, Verrier M, Green J, Menon M, Applegate R, Arias A, Pineiro N, Uppington J, Wolinsky P, Gunnett A, Hagen J, Harris S, Hollen K, Holloway B, Horodyski MB, Pogue T, Ramani R, Smith C, Woods A, Warrick M, Flynn K, Mongan P, Ranganath Y, Fernholz S, Ingersoll-Weng E, Marian A, Seering M, Sibenaller Z, Stout L, Wagner A, Walter A, Wong C, Orwig D, Goud M, Helker C, Mezenghie L, Montgomery B, Preston P, Schwartz JS, Weber R, Fleisher LA, Mehta S, Stephens-Shields AJ, Dinh C, Chelly JE, Goel S, Goncz W, Kawabe T, Khetarpal S, Monroe A, Shick V, Breidenstein M, Dominick T, Friend A, Mathews D, Lennertz R, Sanders R, Akere H, Balweg T, Bo A, Doro C, Goodspeed D, Lang G, Parker M, Rettammel A, Roth M, White M, Whiting P, Allen BFS, Baker T, Craven D, McEvoy M, Turnbo T, Kates S, Morgan M, Willoughby T, Weigel W, Auyong D, Fox E, Welsh T, Cusson B, Dobson S, Edwards C, Harris L, Henshaw D, Johnson K, McKinney G, Miller S, Reynolds J, Segal BS, Turner J, VanEenenaam D, Weller R, Lei J, Treggiari M, Akhtar S, Blessing M, Johnson C, Kampp M, Kunze K, O'Connor M, Looke T, Tadros R, Vlassakov K, Cardenas L, Bolkus K, Mitrev L, Kwofie MK, Dabiri J, Lobel G, Poler M, Giska M, Sanders D, Schwartz G, Giuca M, Tedore T, Nader A, Bryson G, Troxell K, Kiss G, Choi S, Powell M, Applegate R, Warrick M, Ranganath Y, Chelly JE, Lennertz R, Sanders R, Allen BFS, Kates S, Weigel W, Li J, Wijeysundera DN, Kheterpal S, Moore RH, Smith AK, Tosi LL, Looke T, Mehta S, Fleisher L, Hruslinski J, Ramsey L, Langlois C, Mezenghie L, Montgomery B, Oduwole S, and Rose T
- Subjects
- Aged, Analgesics therapeutic use, Anesthesia, General adverse effects, Canada, Female, Humans, Male, Pain, Pain, Postoperative drug therapy, Patient Satisfaction, Anesthesia, Spinal adverse effects, Hip Fractures surgery
- Abstract
Background: The REGAIN (Regional versus General Anesthesia for Promoting Independence after Hip Fracture) trial found similar ambulation and survival at 60 days with spinal versus general anesthesia for hip fracture surgery. Trial outcomes evaluating pain, prescription analgesic use, and patient satisfaction have not yet been reported., Objective: To compare pain, analgesic use, and satisfaction after hip fracture surgery with spinal versus general anesthesia., Design: Preplanned secondary analysis of a pragmatic randomized trial. (ClinicalTrials.gov: NCT02507505)., Setting: 46 U.S. and Canadian hospitals., Participants: Patients aged 50 years or older undergoing hip fracture surgery., Intervention: Spinal or general anesthesia., Measurements: Pain on postoperative days 1 through 3; 60-, 180-, and 365-day pain and prescription analgesic use; and satisfaction with care., Results: A total of 1600 patients were enrolled. The average age was 78 years, and 77% were women. A total of 73.5% (1050 of 1428) of patients reported severe pain during the first 24 hours after surgery. Worst pain over the first 24 hours after surgery was greater with spinal anesthesia (rated from 0 [no pain] to 10 [worst pain imaginable]; mean difference, 0.40 [95% CI, 0.12 to 0.68]). Pain did not differ across groups at other time points. Prescription analgesic use at 60 days occurred in 25% (141 of 563) and 18.8% (108 of 574) of patients assigned to spinal and general anesthesia, respectively (relative risk, 1.33 [CI, 1.06 to 1.65]). Satisfaction was similar across groups., Limitation: Missing outcome data and multiple outcomes assessed., Conclusion: Severe pain is common after hip fracture. Spinal anesthesia was associated with more pain in the first 24 hours after surgery and more prescription analgesic use at 60 days compared with general anesthesia., Primary Funding Source: Patient-Centered Outcomes Research Institute .
- Published
- 2022
- Full Text
- View/download PDF
49. What Works Best to Engage Participants in Mobile App Interventions and e-Health: A Scoping Review.
- Author
-
Oakley-Girvan I, Yunis R, Longmire M, and Ouillon JS
- Subjects
- Adult, Humans, Mobile Applications, Telemedicine
- Abstract
Background: Despite the growing popularity of mobile app interventions, specific engagement components of mobile apps have not been well studied. Methods: The objectives of this scoping review are to determine which components of mobile health intervention apps encouraged or hindered engagement, and examine how studies measured engagement. Results: A PubMed search on March 5, 2020 yielded 239 articles that featured the terms engagement, mobile app/mobile health, and adult. After applying exclusion criteria, only 54 studies were included in the final analysis. Discussion: Common app components associated with increased engagement included: personalized content/feedback, data visualization, reminders/push notifications, educational information/material, logging/self-monitoring functions, and goal-setting features. On the other hand, social media integration, social forums, poor app navigation, and technical difficulties appeared to contribute to lower engagement rates or decreased usage. Notably, the review revealed a great variability in how engagement with mobile health apps is measured due to lack of established processes. Conclusion: There is a critical need for controlled studies to provide guidelines and standards to help facilitate engagement and its measurement in research and clinical trial work using mobile health intervention apps.
- Published
- 2022
- Full Text
- View/download PDF
50. Display and perception of risk: Analysis of decision support system display and its impact on perceived clinical risk of sepsis-induced health deterioration.
- Author
-
Capan M, Schubel LC, Pradhan I, Catchpole K, Shara N, Arnold R, Schwartz JS, Seagull J, and Miller K
- Subjects
- Hospital Mortality, Humans, Organ Dysfunction Scores, Perception, Decision Support Systems, Clinical, Sepsis complications
- Abstract
Despite acknowledging the value of clinical decision support systems (CDSS) in identifying risk for sepsis-induced health deterioration in-hospitalized patients, the relationship between display features, decision maker characteristics, and recognition of risk by the clinical decision maker remains an understudied, yet promising, area. The objective of this study is to explore the relationship between CDSS display design and perceived clinical risk of in-hospital mortality associated with sepsis. The study utilized data collected through in-person experimental sessions with 91 physicians from the general medical and surgical floors who were recruited across 12 teaching hospitals within the United States. Results of descriptive and statistical analyses provided evidence supporting the impact of display configuration and clinical case severity on perceived risk associated with in-hospital mortality. Specifically, findings showed that a high level of information (represented by the Predisposition, Infection, Response and Organ dysfunction (PIRO) score) and Figure display (as opposed to Text or baseline) increased awareness to recognizing the risk for in-hospital mortality of hospitalized sepsis patients. A CDSS display that synthesizes the optimal features associated with information level and design elements has the potential to enhance the quantification and communication of clinical risk in complex health conditions beyond sepsis.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.